Heteroaryl-phenyl heterobicyclic factor Xa inhibitors

US6506771B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Pharma Company · US

Inventors

• Donald J. P. Pinto · Nazareth, US
• Mimi L. Quan · Newark, US
• Francis J. Woerner · Bear, US
• Renhua Li · Wilmington, US

Key dates

• Filing date: Jun 22, 2001
• Grant date: Jan 14, 2003
• Expiry date: Jun 22, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present application describes heteroaryl-phenyl heterobicycles and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.